World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
35680
World Ranking
7414
National Ranking
3875

Judd W. Moul publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Judd W. Moul sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 778 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Judd W. Moul D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Judd W. Moul sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Judd W. Moul is affiliated with Duke University in the United States and has contributed extensively to medical research, particularly focusing on oncology and prostate cancer. Their body of work includes more than one hundred publications primarily within the field of medicine.

The scientist's research spans several subfields, prominently including pulmonary and respiratory medicine, oncology, cancer research, surgery, and economics and econometrics. These diverse interests underscore a multidisciplinary approach to medical science.

The main topics addressed in their work include prostate cancer diagnosis and treatment, prostate cancer treatment and research, cancer related to lipids and metabolism, intensive care unit cognitive disorders, cardiac anesthesia and surgical outcomes, anesthesia and neurotoxicity research, and lymphoma diagnosis and treatment.

Judd W. Moul has published in several notable venues throughout their career. The most frequent publication venues are:

  • ONCOLOGY
  • The Journal of Urology
  • Prostate Cancer and Prostatic Diseases
  • Urology
  • Urology Practice

The scientist often collaborates with other researchers, including frequent coauthors such as Neck Cancer, Howard S. Höchster, New Brunswick, William J. Gradishar, and Tari A. King, reflecting a collaborative research environment.

Selected recent papers exemplify the range and focus of their research:

  • Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification, 2023, published in Prostate Cancer and Prostatic Diseases
  • A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2), 2020, Clinical Cancer Research
  • Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers, 2022, Annals of Clinical and Translational Neurology
  • Current Frontline Treatment of Diffuse Large B-Cell Lymphoma, 2022, ONCOLOGY
  • A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults, 2020, Journal of Neurology

Best Publications

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

    Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino

  • Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men

    Ted O. Morgan;Steven J. Jacobsen;William F. McCarthy;Debra J. Jacobson

  • Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy

    Anthony V. D’Amico;Judd W. Moul;Peter R. Carroll;Leon Sun

  • Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

    Anthony V. D’Amico;Judd Moul;Peter R. Carroll;Leon Sun

  • Frequent Detection of Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancers

    Jaya P. Gaddipati;David G. McLeod;Howard B. Heidenberg;Isabell A. Sesterhenn

  • Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

    Susan Halabi;Chen-Yen Lin;W. Kevin Kelly;Karim S. Fizazi

  • Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

    Christopher L. Amling;Robert H. Riffenburgh;Leon Sun;Judd W. Moul

  • Prostate specific antigen only progression of prostate cancer

    Judd W. Moul

  • Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

    Gyorgy Petrovics;Aijun Liu;Syed Shaheduzzaman;Bungo Furasato

  • PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

    Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu

  • Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

    Lionel L. Bañez;Robert J. Hamilton;Robert J. Hamilton;Alan W. Partin;Robin T. Vollmer

  • The Changing Face of Prostate Cancer

    Matthew R. Cooperberg;Judd W. Moul;Peter R. Carroll

  • Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility

    O. John Semmes;Ziding Feng;Bao Ling Adam;Lionel L. Banez

  • p53 regulates the expression of the tumor suppressor gene maspin.

    Zhiqiang Zou;Chunling Gao;Akhilesh K. Nagaich;Theresa Connell

  • Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy

    Florian R. Schroeck;Tracey L. Krupski;Leon Sun;David M. Albala

  • Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy

    Jason C. Massengill;Leon Sun;Judd W. Moul;Hongyu Wu

  • Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men

    Judd W. Moul;Isabell A. Sesterhenn;Roger R. Connelly;Thomas Douglas

  • Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results.

    David F. Paulson;Judd W. Moul;Philip J. Walther

  • Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

    Judd W. Moul;Judd W. Moul;Hongyu Wu;Leon Sun;David G. McLEOD

Frequent Co-Authors

David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Thomas J. Polascik
Thomas J. Polascik Duke University
Isabell A. Sesterhenn
Isabell A. Sesterhenn United States Army Research Laboratory
Shiv Srivastava
Shiv Srivastava Uniformed Services University of the Health Sciences
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center
Christopher J. Kane
Christopher J. Kane University of California, San Diego
Anthony V. D'Amico
Anthony V. D'Amico Brigham and Women's Hospital
Leah Gerber
Leah Gerber Duke University
E. David Crawford
E. David Crawford University of California, San Diego
Ming-Hui Chen
Ming-Hui Chen University of Connecticut

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a physician. There are several online degree options and flexible career pathways that support healthcare delivery and management. For registered nurses looking to advance, adn to np bridge programs offer a convenient route to become nurse practitioners through online learning.

If nutrition science interests you, earning an online nutrition degree can open doors in clinical, community, and wellness settings. For those with leadership ambitions, cahme accredited online healthcare administration programs prepare graduates for vital roles in healthcare management and policy, with the advantage of accredited online learning.

Nurses considering a bachelor’s degree can explore if their chosen does rn to bsn require clinicals—some RN to BSN programs have reduced or no clinical requirements, making them flexible for working professionals. These options offer pathways to healthcare careers beyond traditional medical schooling, supporting students with diverse goals in the industry.

Best Scientists Citing Judd W. Moul

Trending Scientists

Recently Published Articles